Potential

Zacks Small Cap Research – SNGX: Presentation Highlights HyBryte Potential in CTCL… – Go Health Pro

by
Zacks Small Cap Research – SNGX: Presentation Highlights HyBryte Potential in CTCL… – Go Health Pro

By David Bautz, PhD NASDAQ:SNGX READ THE FULL SNGX RESEARCH REPORT Business Update Presentation Highlights HyBryte Potential in CTCL In January 2025, Dr. Neal Bhatia presented at two dermatology conferences on “Off-Label Uses of PDT” (photodynamic therapy). Dr. Bhatia is the Director of Clinical Dermatology at Therapeutics Clinical Research, a member of Soligenix’s (NASDAQ:SNGX) scientific … Read more

Unlocking AI’s full potential in procurement with smarter data management – Go Health Pro

by
Unlocking AI’s full potential in procurement with smarter data management – Go Health Pro

Supply chain operations are often stymied by inefficiencies that result in higher costs, longer lead times, and dissatisfied customers. These inefficiencies stem from manual processes that slow operations down, data silos that worsen decision making and a lack of visibility into supply chain activities, including procurement. By implementing cutting-edge AI solutions into supply chain operations, … Read more

Potential $200bn catastrophe loss year in 2025 could recalibrate entire industry: Zaffino, AIG – Go Health Pro

by
Potential 0bn catastrophe loss year in 2025 could recalibrate entire industry: Zaffino, AIG – Go Health Pro

With the recent California wildfires seen as likely to drive the second most costly first-quarter on record for the global insurance and reinsurance industry, AIG CEO Peter Zaffino has warned that a $200 billion annual catastrophe loss year in 2025 could “recalibrate the entire industry.”Zaffino highlighted that, “Much more of the risk is now being … Read more

Zacks Small Cap Research – ENSC Continues to Announce Potential Life-Changing Results – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:ENSC READ THE FULL ENSC RESEARCH REPORT Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing treatments designed to have the same pain-relieving capabilities as opioids but come with the ability to inhibit abuse and overdoses. Opioid abuse is a national crisis, with the CDC estimating over 75,000 deaths … Read more

Zacks Small Cap Research – SDA: SunCar Technology Group’s Growth Potential Supports Price Target of $20.00. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:SDA READ THE FULL SDA RESEARCH REPORT Company Announces New Chief Strategy Officer On January 13, 2025, the SunCar (NASDAQ:SDA) announced that Breaux Walker was appointed Chief Strategy Officer. Mr. Walker will oversee the company’s capital markets strategy, investments, international financing, and investor relations. Mr. Walker has over 25 years of … Read more